Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Strongbridge Biopharma plc (SBBP)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-21Mar-31-21Dec-31-20Sep-30-20Jun-30-20Mar-31-20Dec-31-19Sep-30-19
   10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q
Cash flows from operating activities:          
    Net loss  -13.2-11.8-11.9-3.2-17.3-12.7-9.0-13.8
    Adjustments to reconcile net loss income to net cash used in operating activities:          
        Stock-based compensation  2.12.31.82.11.81.81.52.2
        Amortization of intangible asset  1.31.31.31.31.31.31.31.3
        Change in fair value of warrant liability  -0.70.81.0-6.97.4-0.6-1.3-3.2
        Amortization of debt discounts and debt issuance costs  0.30.30.30.4    
        Accretion of discounts on marketable securities      0.00.0-0.1-0.2
        Depreciation  0.00.00.00.00.00.00.00.0
        Changes in operating assets and liabilities:          
            Accounts receivable  -0.70.00.10.0-0.2-0.41.13.0
            Inventory  0.3-0.90.60.20.20.10.40.8
            Prepaid expenses and other current assets  0.2-1.00.50.5-0.80.10.90.4
            Other assets  0.10.1-0.2-0.10.00.30.20.2
            Accounts payable  -5.14.3-0.1-0.4-3.32.01.40.5
            Accrued and other liabilities  5.7-8.61.70.4-1.2-6.92.12.2
                Net cash used in operating activities  -9.8-13.4-5.0-5.8-12.1-15.2-1.6-6.7
   
Cash flows from investing activities:          
    Sales and maturities of marketable securities      6.314.8  
    Purchases of property and equipment   0.0 0.0  0.00.0
        Net cash (used in) provided by investing activities   0.0 0.06.314.819.6-12.4
   
Cash flows from financing activities:          
    Payments related to tax withholding for net-share settled equity awards  -0.3-0.4 -0.1-0.3-0.1 0.0
    Proceeds from long-term debt, net    10.0-0.19.5   
    Proceeds from exercise of stock options   0.1     0.0
    Proceed from issuance of ordinary shares in connection with at-the-market offering, net   0.0      
        Net cash (used in) provided by financing activities  -0.3-0.210.727.79.2-0.1 0.0
    Net (decrease) increase in cash and cash equivalents  -23.7   2.9   
   
Supplemental disclosures of cash flow information: Cash paid during the year for:          
    Interest  0.50.50.30.30.1   
    Income taxes other, net of refunds   1.30.00.20.5   

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy